Total Payments
$12,156
2022 Payments
$854.63
Companies
15
Transactions
55
Payment Breakdown by Category
Consulting$8,480 (69.8%)
Food & Beverage$2,012 (16.6%)
Travel$1,163 (9.6%)
Other$500.00 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,480 | 4 | 69.8% |
| Food and Beverage | $2,012 | 46 | 16.6% |
| Travel and Lodging | $1,163 | 4 | 9.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $7,508 | 7 | $0 (2019) |
| AQUESTIVE THERAPEUTICS, INC. | $1,060 | 3 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $800.00 | 1 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $628.35 | 2 | $0 (2019) |
| UCB, Inc. | $444.95 | 7 | $0 (2022) |
| LivaNova USA, Inc. | $420.57 | 11 | $0 (2019) |
| EISAI INC. | $405.80 | 7 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $400.00 | 1 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $196.53 | 6 | $0 (2020) |
| Greenwich Biosciences, Inc. | $105.95 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $854.63 | 4 | Biohaven Pharmaceutical Holding Company Ltd. ($800.00) |
| 2021 | $1,470 | 3 | AQUESTIVE THERAPEUTICS, INC. ($1,020) |
| 2020 | $47.66 | 2 | Sunovion Pharmaceuticals Inc. ($47.66) |
| 2019 | $8,952 | 27 | Mallinckrodt Enterprises LLC ($7,508) |
| 2018 | $478.97 | 12 | LivaNova USA, Inc. ($163.26) |
| 2017 | $352.64 | 7 | UCB, Inc. ($100.76) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 03/16/2022 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $14.97 | General |
| 02/02/2022 | AQUESTIVE THERAPEUTICS, INC. | SYMPAZAN (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Neurology | ||||||
| 02/02/2022 | AQUESTIVE THERAPEUTICS, INC. | SYMPAZAN (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Neurology | ||||||
| 12/21/2021 | Biohaven Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 11/29/2021 | AQUESTIVE THERAPEUTICS, INC. | — | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| 02/25/2021 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $49.96 | General |
| Category: Neurology | ||||||
| 05/13/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: CNS | ||||||
| 05/13/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: CNS | ||||||
| 12/11/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/08/2019 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $76.29 | General |
| Category: Neurology | ||||||
| 12/08/2019 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $74.55 | General |
| 12/08/2019 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $37.55 | General |
| Category: Neurology | ||||||
| 06/26/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/14/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Consulting Fee | Cash or cash equivalent | $6,260.00 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/14/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $699.60 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/14/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $226.19 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/14/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $183.41 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/14/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $54.10 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/14/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/14/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/06/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2019 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $39.13 | General |
| Category: Neurology | ||||||
| 04/11/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: AED | ||||||
About Dr. Jason Lerner, M.D
Dr. Jason Lerner, M.D is a Neurodevelopmental Disabilities healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275557191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Lerner, M.D has received a total of $12,156 in payments from pharmaceutical and medical device companies, with $854.63 received in 2022. These payments were reported across 55 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($8,480).
Ad
Practice Information
- Specialty Neurodevelopmental Disabilities
- Location Los Angeles, CA
- Active Since 07/26/2006
- Last Updated 04/04/2012
- Taxonomy Code 2080P0008X
- Entity Type Individual
- NPI Number 1275557191
Products in Payments
- ACTHAR (Biological) $7,508
- OXTELLAR XR (Drug) $628.35
- VNS Therapy (Device) $449.31
- Fycompa (Drug) $405.80
- APTIOM (Drug) $196.53
- Briviact (Drug) $142.12
- Epidiolex (Drug) $105.95
- XCOPRI (Drug) $49.96
- ROSA Brain (Device) $44.83
- SYMPAZAN (Drug) $39.66
- ACTIVA (Device) $25.00
- SABRIL (Drug) $21.80
- ONFI (Drug) $15.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurodevelopmental Disabilities Doctors in Los Angeles
Dr. William Shields, M.d, M.D
Neurodevelopmental Disabilities — Payments: $9.7M
Neurodevelopmental Disabilities $9.7M
Raman Sankar, M.d, M.D
Neurodevelopmental Disabilities — Payments: $1.1M
Neurodevelopmental Disabilities $1.1M
Joyce Wu, M.d, M.D
Neurodevelopmental Disabilities — Payments: $42,273
Neurodevelopmental Disabilities $42,273
Susan Perlman, Md, MD
Neurodevelopmental Disabilities — Payments: $29,551
Neurodevelopmental Disabilities $29,551
Daniel Geschwind, Md, MD
Neurodevelopmental Disabilities — Payments: $10,472
Neurodevelopmental Disabilities $10,472
Dr. Christopher Giza, M.d, M.D
Neurodevelopmental Disabilities — Payments: $6,790
Neurodevelopmental Disabilities $6,790